SYMBICORT® in the Treatment of COPD

A Scientific Research Program to Evaluate the Efficacy of SYMBICORT® 320/9μg in the Treatment of COPD in Real Life Environment by General Practitioners

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00564499

Acronym

SRP COPD

Enrollment

Unknown

Registered

2007-11-28

Start date

2006-03-31

Completion date

2007-05-31

Last updated

2011-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD, Symbicort, General Practitioners

Brief summary

A Scientific Research Program to evaluate the efficacy of SYMBICORT® 320/9μg in the treatment of COPD in real life environment by General Practitioners

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients (m/f) with COPD (GOLD stadium III and IV)

Exclusion criteria

* patients who recently quit smoking (\<3months)

Outcome results